Trial Profile
Comparision of Long Term Renal Function Outcomes for Everolimus (EVR) vs. Sirolimus (SIR) vs. Mycophenolate Acid (MPA) in Patients with Post Kidney Transplant (Ktx)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolic acid (Primary) ; Sirolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 05 May 2017 New trial record
- 03 May 2017 Results presented at the 2017 American Transplant Congress